Professor Mark Rosenthal

Current national competitive grants*

2012

Phase III trial of Concurrent & Adjuvant Temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma
Nowak A, Rosenthal M, Simes J, Ryan G, Drummond K
Cancer Australia Priority-driven Collaborative Cancer Research Scheme ($435,792 over 3 years)

2010

Cooperative Trials Group for Neuro-Oncology (COGNO)
Rosenthal M, Livingstone A
Cancer Australia Support for Cancer Clinical Trials - Existing National Cooperative Oncology groups ($1,252,077 over 2 years)

* Grants administered through the University of Sydney

Send a note

Recipient	Mark Rosenthal
Your name
Your email address
Subject
Message
Verification	In order to prevent spam email, you will need to enter the verification code that appears in the red coloured box to the left.